If At First You Don’t Succeed: VALID Act For Diagnostics Introduced In Congress For Third Time
Executive Summary
The Verifying Accurate, Leading-edge IVCT Development (VALID) Act, which calls for a new regulatory framework for diagnostic tests, has been reintroduced in the US Congress.
You may also be interested in...
Once A Cheerleader For Latest VALID Act For Diagnostics, Pew Now Has Some Reservations
Public policy group The Pew Charitable Trusts is concerned that the latest iteration of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act prioritizes a faster time to market over patient safety. The group had previously signed onto a letter praising the proposed legislation, which aims to build a new regulatory framework for diagnostics in the US.
Patient Advocacy Groups Pressure US Lawmakers To Pass VALID Act For Diagnostics Regulation
The Verifying Accurate, Leading-edge IVCT Development (VALID) Act is the “most comprehensive reform effort to date” for diagnostic tests, a group of 18 patient advocacy organizations has told Congress.
Q&A: Unpacking The Latest VALID Act For Diagnostics
Covington & Burling partner Scott Danzis tells Medtech Insight why diagnostics developers and labs should keep an eye on the third iteration of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act – reintroduced in the US Senate on 24 June – and why the bill has a better shot at becoming law this time.